ID

18011

Descripción

Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00210314

Link

https://clinicaltrials.gov/show/NCT00210314

Palabras clave

Versiones (1)
  1. 13/10/16 13/10/16 -
Subido en

13 de octubre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Lymphoma, B Cell NCT00210314

Inglés

Eligibility Lymphoma, B Cell NCT00210314

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. histological or cytological diagnosis of non-hodgkin's lymphoma.
Descripción

Lymphoma, Non-Hodgkin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0024305
2. diagnostic sample obtained by stereotactic or surgical biopsy, csf cytology examination or vitrectomy.
Descripción

Sample obtained Stereotactic Biopsy | Sample obtained Surgical biopsy | Sample obtained Cerebrospinal Fluid Cytology procedure | Sample obtained Vitrectomy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1277697
UMLS CUI [1,2]
C1711202
UMLS CUI [2,1]
C1277697
UMLS CUI [2,2]
C0370003
UMLS CUI [2,3]
C0565118
UMLS CUI [3,1]
C1277697
UMLS CUI [3,2]
C0007806
UMLS CUI [3,3]
C1305671
UMLS CUI [4,1]
C1277697
UMLS CUI [4,2]
C0042903
3. disease exclusively localized into the central nervous system, cranial nerves or eyes.
Descripción

Disease Localized Central Nervous System | Disease Localized Cranial Nerves | Disease Localized Eyes

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0392752
UMLS CUI [1,3]
C3714787
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0392752
UMLS CUI [2,3]
C0010268
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C0392752
UMLS CUI [3,3]
C0015392
4. untreated patients (patients treated with steroids alone are eligible).
Descripción

Patients untreated | Steroids alone

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0332155
UMLS CUI [2,1]
C0038317
UMLS CUI [2,2]
C0205171
5. at least one measurable lesion.
Descripción

Measurable lesion Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
6. age 18 - 75 years.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
7. ecog performance status < 3
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
8. hbsag-negative and ab anti-hcv-negative serologic status.
Descripción

Hepatitis B surface antigen negative | Hepatitis C Antibodies Serologic Negative

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0919711
UMLS CUI [2,1]
C0166049
UMLS CUI [2,2]
C0205473
UMLS CUI [2,3]
C1513916
9. no known hiv disease or immunodeficiency.
Descripción

HIV | Immunologic Deficiency Syndromes

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019682
UMLS CUI [2]
C0021051
10. adequate bone marrow (plt > 100000 mm3, hb ≥ 9 g/dl, anc ≥ 2.000 mm3), renal (creatinine clearance ≥ 60 ml/min), cardiac (vef ≥ 50%), and hepatic function (total serum bilirubin < 3 mg/dl, ast/alt and ggt < 2 per upper normal limit value).
Descripción

Bone Marrow function | Platelet Count measurement | Hemoglobin | Absolute neutrophil count | Renal function | Creatinine clearance measurement | Cardiac function | Ventricular Ejection Fraction | Liver function | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Gamma glutamyl transferase measurement

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0032181
UMLS CUI [3]
C0019046
UMLS CUI [4]
C0948762
UMLS CUI [5]
C0232804
UMLS CUI [6]
C0373595
UMLS CUI [7]
C0232164
UMLS CUI [8]
C0042508
UMLS CUI [9]
C0232741
UMLS CUI [10]
C1278039
UMLS CUI [11]
C0201899
UMLS CUI [12]
C0201836
UMLS CUI [13]
C0202035
11. no previous or concurrent malignancies with the exception of surgically cured cervical intraepithelial neoplasia type 1 (cin1) or localized non-melanomatous skin cancer and of other cancers without evidence of disease since at least 5 years (patients with a previous lymphoma diagnosis will be excluded).
Descripción

Malignant Neoplasms | Cervical intraepithelial neoplasia grade 1 Cure of disease surgical | Skin carcinoma Localized | Lymphoma Previous

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0349458
UMLS CUI [2,2]
C0679252
UMLS CUI [2,3]
C0543467
UMLS CUI [3,1]
C0699893
UMLS CUI [3,2]
C0392752
UMLS CUI [4,1]
C0024299
UMLS CUI [4,2]
C0205156
12. absence of any familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule.
Descripción

Condition Affecting Protocol Compliance

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0525058
13. non-pregnant and non-lactating status for female patients. adequate contraceptive measures during study participation for sexually active patients of childbearing potential.
Descripción

Pregnancy | Breast Feeding | Childbearing Potential Sex Behavior Contraceptive methods

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0036864
UMLS CUI [3,3]
C0700589
14. no concurrent treatment with other experimental drugs.
Descripción

Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013230
15. informed consent signed by the patient before registration
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Volver a la parte superior de la página

Similar models

Eligibility Lymphoma, B Cell NCT00210314

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Lymphoma, Non-Hodgkin
Item
1. histological or cytological diagnosis of non-hodgkin's lymphoma.
boolean
C0024305 (UMLS CUI [1])
Sample obtained Stereotactic Biopsy | Sample obtained Surgical biopsy | Sample obtained Cerebrospinal Fluid Cytology procedure | Sample obtained Vitrectomy
Item
2. diagnostic sample obtained by stereotactic or surgical biopsy, csf cytology examination or vitrectomy.
boolean
C1277697 (UMLS CUI [1,1])
C1711202 (UMLS CUI [1,2])
C1277697 (UMLS CUI [2,1])
C0370003 (UMLS CUI [2,2])
C0565118 (UMLS CUI [2,3])
C1277697 (UMLS CUI [3,1])
C0007806 (UMLS CUI [3,2])
C1305671 (UMLS CUI [3,3])
C1277697 (UMLS CUI [4,1])
C0042903 (UMLS CUI [4,2])
Disease Localized Central Nervous System | Disease Localized Cranial Nerves | Disease Localized Eyes
Item
3. disease exclusively localized into the central nervous system, cranial nerves or eyes.
boolean
C0012634 (UMLS CUI [1,1])
C0392752 (UMLS CUI [1,2])
C3714787 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C0392752 (UMLS CUI [2,2])
C0010268 (UMLS CUI [2,3])
C0012634 (UMLS CUI [3,1])
C0392752 (UMLS CUI [3,2])
C0015392 (UMLS CUI [3,3])
Patients untreated | Steroids alone
Item
4. untreated patients (patients treated with steroids alone are eligible).
boolean
C0030705 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0038317 (UMLS CUI [2,1])
C0205171 (UMLS CUI [2,2])
Measurable lesion Quantity
Item
5. at least one measurable lesion.
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Age
Item
6. age 18 - 75 years.
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
7. ecog performance status < 3
boolean
C1520224 (UMLS CUI [1])
Hepatitis B surface antigen negative | Hepatitis C Antibodies Serologic Negative
Item
8. hbsag-negative and ab anti-hcv-negative serologic status.
boolean
C0919711 (UMLS CUI [1])
C0166049 (UMLS CUI [2,1])
C0205473 (UMLS CUI [2,2])
C1513916 (UMLS CUI [2,3])
HIV | Immunologic Deficiency Syndromes
Item
9. no known hiv disease or immunodeficiency.
boolean
C0019682 (UMLS CUI [1])
C0021051 (UMLS CUI [2])
Bone Marrow function | Platelet Count measurement | Hemoglobin | Absolute neutrophil count | Renal function | Creatinine clearance measurement | Cardiac function | Ventricular Ejection Fraction | Liver function | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Gamma glutamyl transferase measurement
Item
10. adequate bone marrow (plt > 100000 mm3, hb ≥ 9 g/dl, anc ≥ 2.000 mm3), renal (creatinine clearance ≥ 60 ml/min), cardiac (vef ≥ 50%), and hepatic function (total serum bilirubin < 3 mg/dl, ast/alt and ggt < 2 per upper normal limit value).
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0032181 (UMLS CUI [2])
C0019046 (UMLS CUI [3])
C0948762 (UMLS CUI [4])
C0232804 (UMLS CUI [5])
C0373595 (UMLS CUI [6])
C0232164 (UMLS CUI [7])
C0042508 (UMLS CUI [8])
C0232741 (UMLS CUI [9])
C1278039 (UMLS CUI [10])
C0201899 (UMLS CUI [11])
C0201836 (UMLS CUI [12])
C0202035 (UMLS CUI [13])
Malignant Neoplasms | Cervical intraepithelial neoplasia grade 1 Cure of disease surgical | Skin carcinoma Localized | Lymphoma Previous
Item
11. no previous or concurrent malignancies with the exception of surgically cured cervical intraepithelial neoplasia type 1 (cin1) or localized non-melanomatous skin cancer and of other cancers without evidence of disease since at least 5 years (patients with a previous lymphoma diagnosis will be excluded).
boolean
C0006826 (UMLS CUI [1])
C0349458 (UMLS CUI [2,1])
C0679252 (UMLS CUI [2,2])
C0543467 (UMLS CUI [2,3])
C0699893 (UMLS CUI [3,1])
C0392752 (UMLS CUI [3,2])
C0024299 (UMLS CUI [4,1])
C0205156 (UMLS CUI [4,2])
Condition Affecting Protocol Compliance
Item
12. absence of any familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule.
boolean
C0348080 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
Pregnancy | Breast Feeding | Childbearing Potential Sex Behavior Contraceptive methods
Item
13. non-pregnant and non-lactating status for female patients. adequate contraceptive measures during study participation for sexually active patients of childbearing potential.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0036864 (UMLS CUI [3,2])
C0700589 (UMLS CUI [3,3])
Investigational New Drugs
Item
14. no concurrent treatment with other experimental drugs.
boolean
C0013230 (UMLS CUI [1])
Informed Consent
Item
15. informed consent signed by the patient before registration
boolean
C0021430 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial